ThyCa News

ThyCa Names Physicians From Four States and France to Medical Advisory Council

02/2009

ThyCa: Thyroid Cancer Survivors’ Association, Inc. is pleased to announce that six distinguished physicians have been named to its Medical Advisory Council, which now has 28 members.

These specialists are involved in thyroid cancer treatment and research at major centers in several states and France. They include two endocrinologists, two medical oncologists, and two surgeons,

  • Bryan McIver, M.B., Ch.B., Ph.D., Endocrinologist, chairs the Thyroid Group within the Division of Endocrinology at Mayo Clinic in Rochester, Minnesota. Dr. McIver directs a research laboratory and has extensive experience treating patients with aggressive cancers such as anaplastic thyroid cancer and other advanced thyroid cancers.
  • Mira Milas, M.D., Endocrine Surgeon, Cleveland Clinic Foundation, Cleveland, Ohio, is also Associate Professor at the Cleveland Clinic Lerner College of Medicine. She is also involved in research as well as in training other medical professionals. She served on the faculty for the course Advances in Diagnostic and Interventional Endocrine Neck Ultrasound, sponsored by the American Association of Clinical Endocrinologists.
  • Scot C. Remick, M.D., Medical Oncologist, is Director of the Mary Babb Randolph Cancer Center at West Virginia University, Morgantown, West Virginia, following his work with numerous cancer clinical trials at the Case Comprehensive Cancer Center, Cleveland, Ohio. He currently directs a Phase III study assessing a potential new treatment for anaplastic thyroid cancer.
  • Martin J. Schlumberger, M.D., Institut Gustave Roussy, University Paris Sud, Paris, France, is Professor of Oncology and Chairman of the Department of Nuclear Medicine and Endocrine Oncology, where he is involved in treatment and research related to advanced thyroid cancer.
  • Manisha H. Shah, M.D., Medical Oncologist, Ohio State University, Columbus, Ohio, is involved in research and clinical trials of new treatments for medullary and anaplastic thyroid cancer, and for metastatic papillary and follicular thyroid cancer unresponsive to radioiodine.
  • Samuel A. Wells, M.D., Surgeon and specialist in Medullary Thyroid Cancer, is Professor of Medicine at Washington University School of Medicine in St. Louis, Missouri, as well as Executive Director of the International Thyroid Oncology Group, following his prior positions at Duke University School of Medicine, Durham, North Carolina.

The 28 members of ThyCa’s Medical Advisory Council are world- recognized experts in the field of thyroid cancer. The advisors provide valuable counsel and support ThyCa's goals in education, treatment, and research.

Also on the Medical Advisory Council are:

  • Kenneth D. Burman, M.D., Endocrinologist, Washington Hospital Center, Washington, DC
  • Mark S. Chambers, D.M.D., M.S., Dentist/Oral Oncologist, University of Texas M.D. Anderson Cancer Center, Houston, TX
  • Jeffrey A. Cooper, M.D., Nuclear Medicine Physician, Huron Consulting Group, Washington, DC
  • Robert F. Gagel, M.D., Endocrinologist, University of Texas M.D. Anderson Cancer Center, Houston, TX
  • Janis I. Halzel, Pharm.D., Pharmacist, Halzel and Associates, Denver, CO
  • Bryan R. Haugen M.D., Endocrinologist, University of Colorado Health Sciences Center, Denver, CO
  • Paul W. Ladenson, M.D., Endocrinologist, Johns Hopkins Medical Institutions, Baltimore, MD
  • Stephanie L. Lee, M.D., Ph.D., Endocrinologist, Boston Medical Center, Boston, MA
  • Donald Margouleff, M.D., Nuclear Medicine Physician, North Shore University Hospital, Manhasset, NY
  • Ernest L. Mazzaferri, M.D., Endocrinologist, University of Florida Shands Cancer Center, Gainesville, FL
  • Jeffrey F. Moley, M.D., Surgeon, Washington University in St. Louis, School of Medicine, St. Louis, MO
  • David Myssiorek, M.D., Otolaryngologist, New York University Clinical Cancer Center, New York, NY
  • Yolanda C. Oertel, M.D., Cytopathologist, Washington Hospital Center, Washington, DC
  • Matthew D. Ringel, M.D., Endocrinologist, Ohio State University Comprehensive Cancer Center, Columbus, OH
  • Arturo R. Rolla, M.D., Endocrinologist, Beth Israel Deaconess Medical Center, Boston, MA
  • Pamela Schultz, Ph.D., R.N., M.S., Nursing Professor/Researcher, New Mexico State University, Las Cruces, NM
  • Steven I. Sherman, M.D., Endocrinologist, University of Texas M.D. Anderson Cancer Center, Houston, TX
  • Peter A. Singer, M.D., Endocrinologist, University of Southern California Keck School of Medicine, Los Angeles, CA
  • Monica C. Skarulis, M.D., Endocrinologist, National Institutes of Health, Bethesda, MD
  • Carole A. Spencer, Ph.D., F.A.C.B., Thyroglobulin Researcher, University of Southern California Endocrine Services Laboratory, Los Angeles, CA
  • R. Michael Tuttle, M.D., Endocrinologist, Memorial Sloan-Kettering Cancer Center, New York, NY
  • Douglas Van Nostrand, M.D., Nuclear Medicine Physician, Washington Hospital Center, Washington, DC

The Medical Advisors page linked from ThyCa’s web site Home Page gives the names, specialties, and affiliations of all the Medical Advisory Council members: http://www.thyca.org/medical_advisors.htm

More than 50 distinguished specialists provide ongoing review and input for ThyCa’s web site and materials. The web site (www.thyca.org) has more than 650 pages of thyroid cancer information, numerous free downloadable publications, connections with support services and support group meetings, workshop and conference announcements, and other resources.

ThyCa: Thyroid Cancer Survivors’ Association, Inc. is a national nonprofit 501(c) (3) organization of thyroid cancer survivors, families, and health care professionals, advised by internationally recognized thyroid cancer specialists. The organization is dedicated to support, education, and communication for thyroid cancer survivors, their families and friends.

ThyCa also sponsors Thyroid Cancer Awareness Month, year-round awareness activities, and thyroid cancer research fundraising and research grants.

The 12th International Thyroid Cancer Survivors’ Conference will take place in Boston, Massachusetts on October 16-18, 2009.

For more information about ThyCa’s free support services, education, publications, spring workshops, and annual international conference, e-mail to thyca@thyca.org, call toll-free 1-877-588-7904, write to PO Box 1545, New York, NY 10159-1545, or visit the ThyCa web site.


News Archive